Product Information
PHENTERMINE 37.5 MG TABLET is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.0708 per EA under NDC 11534016030. Its NADAC has been published 372 times since May 15, 2019.
Strength
37.5 mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534016030
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205008On Market Since
1/24/2017
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG TABLET has been published 372 times since May 15, 2019, and over the history we have for it it has declined 22.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0708 per EA |
|---|---|
| All-time high | $0.1061 (Jul 10, 2019) |
| All-time low | $0.0494 (Nov 20, 2024) |
| 52-week high | $0.0777 |
| 52-week low | $0.0670 |
| Median price | $0.0810 |
| Average price | $0.0803 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 372 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG TABLET, manufactured by Sunrise Pharmaceutical Inc., is $0.0708 per EA (NDC 11534016030), effective Jun 24, 2026.
How has the price of PHENTERMINE 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG TABLET has declined 22.4%. It has been tracked across 372 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG TABLET?
Since May 15, 2019, the NADAC for PHENTERMINE 37.5 MG TABLET has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.1061 (Jul 10, 2019), with a median of $0.0810 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PHENTERMINE 37.5 MG TABLET, but none are currently priced below it.
Who manufactures PHENTERMINE 37.5 MG TABLET?
PHENTERMINE 37.5 MG TABLET (NDC 11534016030) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification